Drug profile · INN
nicotine
NICABATE P
nicotine (NICABATE P) is a neuronal acetylcholine receptor; alpha4/beta2 agonist. Associated with HALEON AUSTRALIA PTY LTD. Route of administration: nasal. Current US regulatory status: approved.
Drug details — nicotine
- US status
- approved
- Class
- —
- Route
- NASAL
- Patents
- 20
- Programs
- 99
- Data quality
- 0.84
Quick answer
nicotine (NICABATE P) is a neuronal acetylcholine receptor; alpha4/beta2 agonist. Associated with HALEON AUSTRALIA PTY LTD. Route of administration: nasal. Current US regulatory status: approved.
Key facts
Mechanism of action
Neuronal acetylcholine receptor; alpha4/beta2 agonist
Primary target: Neuronal acetylcholine receptor; alpha4/beta2
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12274710
Compound for regulating body weight imbalance, composition thereof and application thereof
granted -
US 12084670
Regulating alkaloids
granted -
US 11865155
Plant extract obtained from Morus plant leaves which has an IC50 value to inhibit a-glucosidase I at a concentration of less than 90 uG/ml, compositions containing same, method of extraction and uses thereof
granted -
US 11712467
Methods of rational nicotine hapten design and uses thereof
granted -
US 11667924
Increasing levels of nicotinic alkaloids in plants
granted -
US 11597916
Nicotine degrading enzyme variants
granted -
US 11572568
Regulating alkaloids
granted -
US 11357848
Methods of rational nicotine hapten design and uses thereof
granted -
US 11090349
Plant extract obtained from Morus plant leaves, compositions containing same, method of extraction and uses thereof
granted -
US 10907170
Increasing levels of nicotinic alkaloids in plants
granted -
US 10829774
Increasing levels of nicotinic alkaloids in plants
granted -
US 10731172
Regulating alkaloids
granted -
US 10287596
Regulating alkaloids
granted -
US 10190129
Increasing levels of nicotinic alkaloids in plants
granted -
US 10182994
Nanoparticulate complex of nicotine and cerium oxide and use thereof
granted -
US 10016474
Plant extract, compositions containing same, method of extraction and uses thereof
granted -
US 9994860
Regulating alkaloids
granted -
US 9884114
Methods of rational nicotine hapten design and uses thereof
granted -
US 9719103
Increasing levels of nicotinic alkaloids in plants
granted -
US 9551003
Increasing levels of nicotinic alkaloids in plants
granted
Frequently asked questions
What is nicotine?
nicotine (NICABATE P) is a neuronal acetylcholine receptor; alpha4/beta2 agonist. Associated with HALEON AUSTRALIA PTY LTD. Route of administration: nasal. Current US regulatory status: approved.
What is the brand name for nicotine?
NICABATE P is a marketed brand name for nicotine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nicotine?
nicotine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.